海外の治験の状況「COVID-19」での検索結果
23件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- Implementing PTSD Treatment in FQHCs for Michigan Medicaid Enrollees
- PTSD
- United States
- 2018-10-12
Recruiting
- A Safety and Pharmacokinetic Study of IGM-2323 in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma
- Non-Hodgkin Lymphoma;Follicular Lymphoma;DLBCL;Mantle Cell Lymphoma;Marginal Zone Lymphoma
- United States
- 2019-09-04
Recruiting
- Evaluation of 19-gauge vs 21-gauge EBUS TBNA in Assessing Thoracic Lymphadenopathy
- Enlarged Lymph Nodes (Excluding Infective);Enlarged Lymph Nodes (Excluding Infective)
- United States
- 2018-07-31
Recruiting
- Study of 177Lu Human Monoclonal Antibody 5B1 (MVT-1075) in Combination With a Blocking Dose of MVT-5873 as Radioimmunotherapy
- Pancreatic Carcinoma;Tumors That Express CA 19-9;Pancreatic Carcinoma;Tumors That Express CA 19-9;Pancreatic Carcinoma;Tumors That Express CA 19-9
- United States
- 2017-03-23
Recruiting
- Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
- Severe Combined Immunodeficiency (SCID);Immunodeficiency With Predominant T-cell Defect, Unspecified;Severe Chronic Neutropenia;Chronic Granulomatous Disease (CGD);Hyper IgE Syndromes;Hyper IgM Deficiencies;Wiskott-Aldrich Syndrome;Mendelian Susceptibility to Mycobacterial Disease;Common Variable Immune Deficiency (CVID)
- United States
- 2013-04-26
Recruiting
- Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
- ALK Gene Rearrangement;EGFR Exon 19 Deletion Mutation;EGFR NP_005219.2:p.L858R;Stage IB Non-Small Cell Lung Carcinoma AJCC v7;Stage II Non-Small Cell Lung Cancer AJCC v7;Stage IIA Non-Small Cell Lung Carcinoma AJCC v7;Stage IIB Non-Small Cell Lung Carcinoma AJCC v7;Stage IIIA Non-Small Cell Lung Cancer AJCC v7
- United States
- 2014-07-15
Recruiting
- Osimertinib and Navitoclax in Treating Patients With EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer
- Advanced Lung Non-Squamous Non-Small Cell Carcinoma;EGFR Activating Mutation;EGFR Exon 19 Deletion Mutation;EGFR NP_005219.2:p.G719X;EGFR NP_005219.2:p.L858R;EGFR NP_005219.2:p.L861Q;EGFR NP_005219.2:p.T790M;Metastatic Lung Non-Squamous Non-Small Cell Carcinoma;Stage III Non-Small Cell Lung Cancer AJCC v7;Stage IIIA Non-Small Cell Lung Cancer AJCC v7;Stage IIIB Lung Non-Small Cell Cancer AJCC v7;Stage IV Non-Small Cell Lung Cancer AJCC v7
- United States
- 2015-08-10
Recruiting
- Sapanisertib and Osimertinib in Treating Patients With Stage IV EGFR Mutation Positive Non-small Cell Lung Cancer After Progression on a Previous EGFR Tyrosine Kinase Inhibitor
- EGFR Activating Mutation;EGFR Exon 19 Deletion Mutation;EGFR NP_005219.2:p.G719X;EGFR NP_005219.2:p.L858R;EGFR NP_005219.2:p.L861Q;EGFR T790M Mutation Negative;Recurrent Lung Non-Small Cell Carcinoma;Stage III Non-Small Cell Lung Cancer AJCC v7;Stage IIIA Non-Small Cell Lung Cancer AJCC v7;Stage IIIB Lung Non-Small Cell Cancer AJCC v7;Stage IV Non-Small Cell Lung Cancer AJCC v7
- Canada, United States
- 2015-07-20
Recruiting
- Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
- EGFR Exon 19 Deletion Mutation;EGFR Exon 20 Insertion Mutation;EGFR NP_005219.2:p.G719X;EGFR NP_005219.2:p.L858R;EGFR NP_005219.2:p.L861Q;EGFR NP_005219.2:p.T790M;EGFR T790M Mutation Negative;Metastatic Lung Non-Small Cell Carcinoma;Recurrent Lung Non-Small Cell Carcinoma;Stage IV Non-Small Cell Lung Cancer AJCC v7
- United States
- 2015-07-09
Recruiting
- Immune Disorder HSCT Protocol
- Immune Deficiency Disorders;Severe Combined Immunodeficiency;Chronic Granulomatous Disease;X-linked Agammaglobulinemia;Wiskott-Aldrich Syndrome;Hyper-IgM;DiGeorge Syndrome;Chediak-Higashi Syndrome;Common Variable Immune Deficiency;Immune Dysregulatory Disorders;Hemophagocytic Lymphohistiocytosis;IPEX;Autoimmune Lymphoproliferative Syndrome;X-linked Lymphoproliferative Syndrome
- United States
- 2013-03-19
